The Future is Trippy? The FDA Starts Its First-Ever Study on Magic Mushrooms and Psychedelics

The Future is Trippy? The FDA Starts Its First-Ever Study on Magic Mushrooms and Psychedelics
Cannabis.net

The US Food and Drug Administration (FDA) just green-lighted Filament Health Corporation, a clinical-stage company in the natural psychedelic medicine development business, to do a study on the effects of certain psychedelic drugs. Filament has already created around 70 strains of psychedelic mushrooms to be used for research, and they were able to raise a cool $2.5 million to continue studying the use of psychedelics through stabilized formulas. These would offer patients the benefits of better bioavailability, consistency, and a quicker onset as well as a reduction in side effects.

Excerpt only …
READ MORE BELOW
Source : The Future is Trippy? The FDA Starts Its First-Ever Study on Magic Mushrooms and Psychedelics

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.